AMA Wants To Stop Pharma Pay-To-Delay Tactic On Generics

The latest coming from the American Medical Association, the nation’s largest doctor group . . .

AMA Wants To Stop Pharma Pay-To-Delay Tactic On Generics - Forbes:

"An end to the drug industry practice that leads to drug makers legally paying a competitor to keep a cheaper generic off the market for potentially years would be bad news to drug makers like Abbott Laboratories (ABT), Pfizer (PFE) and others but good news for companies that operate pharmacies like Walgreen (WAG), CVS/Caremark (CVS) and Wal-Mart (WMT) which try to get consumers to switch to less expensive prescriptions."

'via Blog this'

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
SkillsPlus Intl Info Blog
The Health, Drug, Prescription, and GMP Supersite Gift Store